Eli Lilly and Company - Ebitda Per Share

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD.

The item "Ebitda-Per-Share" stands at 30.46 United States Dollars as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Eli Lilly and Company's third quarter, the item "Ebitda Per Share" stands at 30.46 USD. This represents an increase of 34.41 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 110.35 percent compared to the value the year prior.
The 1 year change in percent is 110.35.
The 3 year change in percent is 220.04.

The Serie's long term average value is 13.69 United States Dollars. It's latest available value, on 09/30/2025, is 122.51 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is +228.46%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.